Search - tctmd.com

Displaying 241 - 260 of 276

Presentation TCT 2012

Multicenter Clinical Trial with Everolimus-Eluting stent for the treatment of Bare-Metal in-stent restenosis. Immediate and long-term clinical and angiographic outcome

Presenter: Didier Carri?, Nicolas Delarche, Christophe Piot, Jacques Berland, Nicolas Meneveau, Laurent Benello, Antoine Py, Emmanuel Teiger, Laurent Leborgne, Gilles Bayet, Olivier Wittenberg

January 03, 2012

Presentation TCT 2012

Current Treatment and Outcome of Coronary In-Stent Restenosis – Report from the Swedish Angiography and Angioplasty Registry (SCAAR)

Presenter: Torsten Schwalm, J?rg Carlsson, Bo Lagerqvist, Stefan James

January 03, 2012

News Conference News

ROTAXUS: Rotablation Does Not Improve Stenting Results in Calcified Lesions

Yael L. Maxwell

November 30, 2011

News Conference News

COBRA: Postdilation with Cryoplasty Reduces Restenosis in Diabetic SFA Lesions

Jason Kahn

November 30, 2011

News Daily News

Some New-Generation Stents Prone to Longitudinal Distortion

November 29, 2011

News Conference News

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

November 27, 2011

News Conference News

RIBS III: Alternative DES Best Bet for DES In-Stent Restenosis

November 22, 2011

News Conference News

Drug-Eluting Balloons an Option for Patients with BMS Restenosis, High Bleeding Risk

November 17, 2011

News Conference News

PRISM Individualized Informed Consent Improves PCI Choice, Experience

November 14, 2011

News Industry News

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

November 13, 2011

News Daily News

First DES for Above-the-Knee Vascular Disease on the Horizon

L.A. McKeown

October 18, 2011

News Daily News

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

September 14, 2011

News Daily News

TRIAS HR Published: Genous Stent Doubles Target Lesion Failure

Leah Lawrence

August 23, 2011

News Daily News

Selective Use of DES Saves Millions of Dollars a Year

Jason Kahn

August 15, 2011

News Daily News

Angioplasty May Be Alternative to Surgery for Common Femoral Artery Disease

Jason Kahn

August 08, 2011

News Daily News

SES Fractures Raise Revascularization Risk, But Not Beyond 1 Year

Caitlin E. Cox

August 05, 2011

News Daily News

ESSENCE-DIABETES Published: Xience, Cypher Equally Equipped to Treat Diabetics

Caitlin E. Cox

August 03, 2011

News Daily News

ISAR-TEST 5 Published: Polymer-Free Dual DES Noninferior to Resolute

Jason Kahn

July 21, 2011

News Daily News

DES Show Advantage over BMS for Heart Transplant Complication

L.A. McKeown

July 01, 2011

News Daily News

Study Takes Clopidogrel into Account in Assessing DES Cost-Effectiveness

Caitlin E. Cox

June 24, 2011

Advertisement

Multicenter Clinical Trial with Everolimus-Eluting stent for the treatment of Bare-Metal in-stent restenosis. Immediate and long-term clinical and angiographic outcome

Current Treatment and Outcome of Coronary In-Stent Restenosis – Report from the Swedish Angiography and Angioplasty Registry (SCAAR)

ROTAXUS: Rotablation Does Not Improve Stenting Results in Calcified Lesions

COBRA: Postdilation with Cryoplasty Reduces Restenosis in Diabetic SFA Lesions

Some New-Generation Stents Prone to Longitudinal Distortion

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

RIBS III: Alternative DES Best Bet for DES In-Stent Restenosis

Drug-Eluting Balloons an Option for Patients with BMS Restenosis, High Bleeding Risk

PRISM Individualized Informed Consent Improves PCI Choice, Experience

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

First DES for Above-the-Knee Vascular Disease on the Horizon

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

TRIAS HR Published: Genous Stent Doubles Target Lesion Failure

Selective Use of DES Saves Millions of Dollars a Year

Angioplasty May Be Alternative to Surgery for Common Femoral Artery Disease

SES Fractures Raise Revascularization Risk, But Not Beyond 1 Year

ESSENCE-DIABETES Published: Xience, Cypher Equally Equipped to Treat Diabetics

ISAR-TEST 5 Published: Polymer-Free Dual DES Noninferior to Resolute

DES Show Advantage over BMS for Heart Transplant Complication

Study Takes Clopidogrel into Account in Assessing DES Cost-Effectiveness

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content